- Home
- ALLR vs AMZE Comparison
ALLR vs AMZE Comparison
Compare ALLR & AMZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- AMZE
- Stock Information
- Founded
- ALLR 2004
- AMZE 2019
- Country
- ALLR United States
- AMZE United States
- Employees
- ALLR N/A
- AMZE N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- AMZE Beverages (Production/Distribution)
- Sector
- ALLR Health Care
- AMZE Consumer Staples
- Exchange
- ALLR Nasdaq
- AMZE Nasdaq
- Market Cap
- ALLR 15.8M
- AMZE 16.1M
- IPO Year
- ALLR N/A
- AMZE 2021
- Fundamental
- Price
- ALLR $1.66
- AMZE $2.78
- Analyst Decision
- ALLR Strong Buy
- AMZE
- Analyst Count
- ALLR 1
- AMZE 0
- Target Price
- ALLR $9.00
- AMZE N/A
- AVG Volume (30 Days)
- ALLR 21.5M
- AMZE 47.4K
- Earning Date
- ALLR 08-15-2025
- AMZE 08-14-2025
- Dividend Yield
- ALLR N/A
- AMZE N/A
- EPS Growth
- ALLR N/A
- AMZE N/A
- EPS
- ALLR N/A
- AMZE N/A
- Revenue
- ALLR N/A
- AMZE $1,054,111.00
- Revenue This Year
- ALLR N/A
- AMZE $6,741.66
- Revenue Next Year
- ALLR N/A
- AMZE $100.61
- P/E Ratio
- ALLR N/A
- AMZE N/A
- Revenue Growth
- ALLR N/A
- AMZE N/A
- 52 Week Low
- ALLR $0.61
- AMZE $1.57
- 52 Week High
- ALLR $3.91
- AMZE $28.72
- Technical
- Relative Strength Index (RSI)
- ALLR 59.12
- AMZE 43.60
- Support Level
- ALLR $1.78
- AMZE $1.57
- Resistance Level
- ALLR $1.92
- AMZE $2.68
- Average True Range (ATR)
- ALLR 0.25
- AMZE 0.35
- MACD
- ALLR 0.02
- AMZE 0.14
- Stochastic Oscillator
- ALLR 52.25
- AMZE 72.89
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About AMZE Amaze Holdings Inc. Common Stock
Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.